AlzChem Group
ACT.DE
#4988
Rank
HK$13.11 B
Marketcap
HK$1,244
Share price
1.93%
Change (1 day)
151.25%
Change (1 year)

P/E ratio for AlzChem Group (ACT.DE)

P/E ratio as of December 2025 (TTM): 25.2

According to AlzChem Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.1802. At the end of 2023 the company had a P/E ratio of 7.34.

P/E ratio history for AlzChem Group from 2018 to 2025

PE ratio at the end of each year

Year P/E ratio Change
20237.3441.02%
20225.20-30.53%
20217.49-19.51%
20209.30-5.56%
20199.85363.47%
20182.13-13.04%
20172.44-106.44%
2016-38.07.82%
2015-35.2-74.19%
2014-136-0%
2013-136-21.92%
2012-175-25.88%
2011-236183.21%
2010-83.3-69.78%
2009-275-60.59%
2008-699

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.